Inotiv, Inc.
NOTV
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, noncā¦ read more
Healthcare
Diagnostics & Research
28 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.87
Price+4.35%
$0.04
1Y
Price
Market Cap
$29.910m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+6.4%
EBITDA Margin-13.4%
Net Profit Margin-8.8%
Free Cash Flow MarginRevenue
$505.299m
+3.0%
1y CAGR-2.3%
3y CAGR+126.1%
5y CAGREarnings
-$78.964m
+27.2%
1y CAGR+31.0%
3y CAGR-775.7%
5y CAGREPS
-$2.70
+35.6%
1y CAGR+34.6%
3y CAGR-437.3%
5y CAGRBook Value
$143.785m
$759.737m
Assets$615.952m
Liabilities$15.051m
DebtDebt to Assets
2.0%
0.7x
Debt to EBITDAFree Cash Flow
-$46.365m
-59.2%
1y CAGR-2573.4%
3y CAGR-2506.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company